Oncolytics Biotech Inc (ONC) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.899x

Based on the latest financial reports, Oncolytics Biotech Inc (ONC) has a cash flow conversion efficiency ratio of -0.899x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-5.47 Million ≈ $-3.96 Million USD) by net assets (CA$6.09 Million ≈ $4.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ONC market cap overview for the company's overall valuation and market capitalisation.

Oncolytics Biotech Inc - Cash Flow Conversion Efficiency Trend (1999–2024)

This chart illustrates how Oncolytics Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Oncolytics Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oncolytics Biotech Inc ranked by their cash flow conversion efficiency. Explore earnings quality score of Oncolytics Biotech Inc to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Multitude SE
LSE:0R4W
0.150x
Acusensus Ltd
AU:ACE
0.023x
Punjab Chemicals & Crop Protection Limited
NSE:PUNJABCHEM
0.207x
K2 Capital Acquisition Corporation
NASDAQ:KTWO
-0.003x
Hamat Group Ltd
TA:HAMAT
0.059x
Hooker Furniture Corporation
NASDAQ:HOFT
0.085x
Golden Long Teng Development Co Ltd
TWO:3188
0.098x
PROQR THERAPEUTICS EO-04
F:0PQ
-0.271x

Annual Cash Flow Conversion Efficiency for Oncolytics Biotech Inc (1999–2024)

The table below shows the annual cash flow conversion efficiency of Oncolytics Biotech Inc from 1999 to 2024. View ONC stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CA$5.98 Million
≈ $4.33 Million
CA$-26.97 Million
≈ $-19.51 Million
-4.507x -336.69%
2023-12-31 CA$27.56 Million
≈ $19.94 Million
CA$-28.45 Million
≈ $-20.58 Million
-1.032x -17.12%
2022-12-31 CA$26.50 Million
≈ $19.17 Million
CA$-23.36 Million
≈ $-16.89 Million
-0.881x -41.80%
2021-12-31 CA$36.10 Million
≈ $26.11 Million
CA$-22.43 Million
≈ $-16.23 Million
-0.621x +30.29%
2020-12-31 CA$24.75 Million
≈ $17.91 Million
CA$-22.07 Million
≈ $-15.96 Million
-0.892x -100.48%
2019-12-31 CA$-107.89K
≈ $-78.05K
CA$-19.91 Million
≈ $-14.40 Million
184.497x +9688.95%
2018-12-31 CA$6.20 Million
≈ $4.48 Million
CA$-11.92 Million
≈ $-8.62 Million
-1.924x -7.03%
2017-12-31 CA$8.28 Million
≈ $5.99 Million
CA$-14.89 Million
≈ $-10.77 Million
-1.798x -54.00%
2016-12-31 CA$10.69 Million
≈ $7.73 Million
CA$-12.48 Million
≈ $-9.03 Million
-1.167x -91.56%
2015-12-31 CA$24.67 Million
≈ $17.85 Million
CA$-15.03 Million
≈ $-10.88 Million
-0.609x +57.21%
2014-12-31 CA$13.82 Million
≈ $10.00 Million
CA$-19.68 Million
≈ $-14.23 Million
-1.424x -29.41%
2013-12-31 CA$22.21 Million
≈ $16.07 Million
CA$-24.44 Million
≈ $-17.68 Million
-1.100x +52.51%
2012-12-31 CA$14.79 Million
≈ $10.70 Million
CA$-34.26 Million
≈ $-24.78 Million
-2.317x -203.39%
2011-12-31 CA$29.52 Million
≈ $21.35 Million
CA$-22.54 Million
≈ $-16.31 Million
-0.764x -77.55%
2010-12-31 CA$41.93 Million
≈ $30.33 Million
CA$-18.03 Million
≈ $-13.05 Million
-0.430x +16.02%
2009-12-31 CA$32.84 Million
≈ $23.76 Million
CA$-16.82 Million
≈ $-12.17 Million
-0.512x +68.33%
2008-12-31 CA$9.45 Million
≈ $6.84 Million
CA$-15.29 Million
≈ $-11.06 Million
-1.617x -233.25%
2007-12-31 CA$27.96 Million
≈ $20.23 Million
CA$-13.57 Million
≈ $-9.82 Million
-0.485x -22.97%
2006-12-31 CA$30.80 Million
≈ $22.28 Million
CA$-12.16 Million
≈ $-8.79 Million
-0.395x -58.73%
2005-12-31 CA$44.45 Million
≈ $32.16 Million
CA$-11.05 Million
≈ $-8.00 Million
-0.249x -3.47%
2004-12-31 CA$38.39 Million
≈ $27.77 Million
CA$-9.22 Million
≈ $-6.67 Million
-0.240x -9.74%
2003-12-31 CA$25.02 Million
≈ $18.10 Million
CA$-5.48 Million
≈ $-3.96 Million
-0.219x +50.03%
2002-12-31 CA$16.56 Million
≈ $11.98 Million
CA$-7.26 Million
≈ $-5.25 Million
-0.438x -63.61%
2001-12-31 CA$15.95 Million
≈ $11.54 Million
CA$-4.27 Million
≈ $-3.09 Million
-0.268x -68.90%
2000-12-31 CA$19.92 Million
≈ $14.41 Million
CA$-3.16 Million
≈ $-2.28 Million
-0.159x -105.58%
1999-12-31 CA$6.93 Million
≈ $5.01 Million
CA$-534.35K
≈ $-386.54K
-0.077x --

About Oncolytics Biotech Inc

TO:ONC Canada Biotechnology
Market Cap
$1.08 Billion
CA$1.50 Billion CAD
Market Cap Rank
#17939 Global
#587 in Canada
Share Price
CA$14.90
Change (1 day)
+0.00%
52-Week Range
CA$14.90 - CA$14.90
All Time High
CA$18.60
About

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative advanced and metastatic breast cancer, metastatic pancreatic ductal aden… Read more